September 17, 2018 Cell Analysis Tools Product Launch

Sphere Fluidics Introduces New Cyto-Mine Studio Software Suite

September 17, 2018 02:07 AM Pacific Daylight Time CAMBRIDGE, England–(BUSINESS WIRE)–Sphere Fluidics, a company commercializing single cell analysis systems underpinned by its patented picodroplet technology, today introduced Cyto-Mine® Studio Software Suite, an updated software for its innovative Cyto-Mine Single Cell Analysis System. The software works alongside industry-standard robotic platforms and corporate databases to improve antibody discovery... Read more

August 13, 2018 Cell Analysis Tools PR/Corporate

Sphere Fluidics Appoints Dr Tris Vaughan (Vice President R&D Antibody Discovery and Protein Engineering for MedImmune) to their Scientific Advisory Board.

August 13, 2018 02:09 AM Pacific Daylight Time CAMBRIDGE, England–(BUSINESS WIRE)–Sphere Fluidics, a company providing single cell analysis systems underpinned by its patented picodroplet technology, announced today that Tris Vaughan, PhD FRSB has joined its scientific advisory board (SAB). Dr Vaughan’s appointment will further strengthen the company’s understanding of biopharmaceutical discovery and cell line development... Read more

January 30, 2018 Cell Analysis Tools

Sphere Fluidics expands Cyto-Mine sales team and distribution in US, Europe and Asia.

Cambridge, UK, 30 January 2018: Sphere Fluidics, a company providing single cell analysis systems underpinned by its patented picodroplet technology, has today announced the expansion of its international commercial operations. The Company is expanding its direct sales and support activity in North America, having recently opened a sales and support operation in New Jersey, and has... Read more

November 24, 2017 Cell Analysis Tools M&A, Partnerships PR/Corporate

Sphere Fluidics and Geneva Biotech receive Eurostars genome editing grant

€1.6 million grant will support ‘precise docking of very large DNA cargoes in genomes’ project Cambridge, UK, and Geneva, Switzerland, 27 November 2017: Sphere Fluidics, a company providing single cell analysis systems underpinned by its patented picodroplet technology, and Geneva Biotech, an EMBL spin-out developing world-class viral and non-viral DNA delivery systems, have received a... Read more